Skip to main content
PolicySpeak
← All files
RG

Radimed GmbH

Company · Germany · EU Transparency Register 2037923101722-49

1
position filed
in the 326 files tracked
1
legislative file
of 326 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 925 companies & groups on this site, they rank #823 by legislative files engaged — a count of participation, not a measure of influence.

0.1
declared lobbying FTE
self-declared
< €10K
declared costs / yr (floor)
1
EP accreditations
as declared to the register
2025
in the register since

Declares membership of

  • SPECTARIS - Deutscher Industrieverband für Optik
  • Photonik
  • Analysen- und Medizintechnik e.V.

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Companies & groups
Registered as
Radimed Gesellschaft für Kommunikationsdienstleistungen und Medizintechnik mbH (Radimed GmbH)
Head office
Bochum, Germany

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Radimed in PolicySpeak: request access →

Work at Radimed GmbH? so we know who speaks for it.

Follow the file Radimed GmbH engages with

One email on Tuesdays when a new position is filed on this file, from Radimed GmbH or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Radimed GmbH filed 1 position on 3 Aug 2026, across 1 of the 326 legislative files tracked here.

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 3 Aug 2026source

As a micro-enterprise, we welcome the Commissions proposal. A risk-based approach that moves away from rigid quotas in market surveillance towards a for cause approach. Even though a specific justification is required for an unannounced audit or sampling by the notified bodies, this approach nevertheless leads to a greater focus on actual risk. For cause does not mean that something must have happened first.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Is this your organization?

Everything on this page comes from Radimed GmbH’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.